Insider Shareholders with Direct Ownership of Spring Works Therapeutics, Inc. (SWTX)
This section provides a comprehensive overview of the insiders with direct ownership of Spring Works Therapeutics, Inc. (SWTX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
SpringWorks Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Pfizer Inc
> 10% Shareholder |
4,593,847 | 0 | 4,593,847 $152 Million | 1 |
Sep 17, 2019
Added 1.08%
|
|
Saqib Islam
Chief Executive Officer |
487,098 | 397,179 | 1,063,368 $35.2 Million | 21 |
Sep 03, 2024
Reduced 0.63%
|
|
Daniel Lynch
Director |
14,667 | 0 | 305,944 $10.1 Million | 4 |
May 16, 2024
Added 1.32%
|
|
Jens Renstrup
Chief Medical Officer |
6,075 | 0 | 250,499 $8.29 Million | 1 |
Jan 07, 2021
Added 2.37%
|
|
L. Mary Smith
Chief Development Officer |
128,836 | 52,575 | 233,363 $7.72 Million | 20 |
Jan 08, 2024
Reduced 1.49%
|
|
Badreddin Edris
Chief Operating Officer |
115,430 | 121,275 | 229,600 $7.6 Million | 13 |
Sep 03, 2024
Reduced 1.32%
|
|
Stephen P Squinto
Director |
5,924 | 21,000 | 131,652 $4.36 Million | 6 |
May 19, 2022
Added 3.53%
|
|
James Cassidy
Chief Medical Officer |
56,591 | 8,565 | 73,856 $2.44 Million | 9 |
Aug 30, 2024
Reduced 2.6%
|
|
Perier I Francis Jr
Chief Financial Officer |
69,390 | 10,676 | 59,253 $1.96 Million | 9 |
Jan 08, 2024
Reduced 5.15%
|
|
Bhavesh Ashar
Chief Commercial Officer |
74,670 | 18,340 | 56,330 $1.86 Million | 12 |
Apr 01, 2024
Reduced 3.14%
|
|
Herschel S Weinstein
General Counsel & Secretary |
60,643 | 8,761 | 52,239 $1.73 Million | 9 |
Jan 08, 2024
Reduced 4.43%
|
|
Michael F. Burgess
Head of Research & Development |
55,359 | 5,775 | 49,584 $1.64 Million | 5 |
Jul 18, 2022
Reduced 5.89%
|
|
Daniel Pichl
Chief People Officer |
93,126 | 48,125 | 45,212 $1.5 Million | 15 |
Feb 16, 2024
Reduced 24.91%
|
|
Michael Nofi
Chief Accounting Officer |
32,565 | 3,991 | 28,727 $950,576 | 9 |
Jan 08, 2024
Reduced 3.57%
|
|
Tai An Lin
Chief Scientific Officer |
29,289 | 2,324 | 26,965 $892,271 | 3 |
Oct 02, 2024
Reduced 7.93%
|
|
Carlos Alban
Director |
18,801 | 0 | 18,801 $622,125 | 3 |
May 16, 2024
Added 17.89%
|
|
Freda C Lewis Hall
Director |
14,667 | 0 | 14,667 $485,331 | 4 |
May 16, 2024
Added 21.83%
|
|
Alan Fuhrman
Director |
14,667 | 0 | 14,667 $485,331 | 4 |
May 16, 2024
Added 21.83%
|
|
Jeffrey Lawrence Schwartz
Director |
10,572 | 0 | 10,572 $349,827 | 3 |
May 24, 2023
Added 30.54%
|
|
Martin Mackay
Director |
9,963 | 0 | 9,963 $329,675 | 1 |
Jul 29, 2024
Added 50.0%
|
|
Julie Hambleton
Director |
14,667 | 10,572 | 4,095 $135,503 | 8 |
Jun 03, 2024
Reduced 0.49%
|